Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.KLY


Primary Symbol: KALTF

Kalytera Therapeutics Inc is a clinical-stage specialty pharmaceutical company developing a portfolio of pharmaceutical products in Canada. It develops new treatments for a variety of diseases and disorders, by discovering, developing, manufacturing, and delivering human therapeutics.


OTCPK:KALTF - Post by User

Comment by AngelaLon Feb 07, 2021 2:26am
163 Views
Post# 32494883

RE:RE:RE:This gives me less and less and less confidence

RE:RE:RE:This gives me less and less and less confidence

As a matter of fact I did check. Salzman has published 157 scientific papers. It was easy to find on the web. 

https://pubmed.ncbi.nlm.nih.gov/?term=Salzman+al&show_snippets=off&sort=date&size=200


 


 


 

<< Previous
Bullboard Posts
Next >>